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Abstract. Syndecan-1 is a cell surface proteoglycan 
containing a highly conserved transmembrane and cy- 
toplasmic domain, and an extracellular domain bearing 
heparan sulfate glycosaminoglycans.  Through these do- 
mains, syndecan-1 is proposed to have roles in growth 
factor action, extracellular matrix adhesion, and cyto- 
skeletal organization that controls cell morphology. To 
study the role of syndecan-1 in cell adhesion and cy- 
toskeleton reorganization, mouse syndecan-1 cDNA 
was transfected into human Raji cells, a lymphoblastoid 
cell line that grows as suspended cells and exhibits little 
or no endogenous cell surface heparan sulfate. High ex- 
pressing transfectants (Raji-S1 cells) bind to and spread 
on immobilized thrombospondin or fibronectin, which 
are ligands for the heparan sulfate chains of the pro- 
teoglycan. This binding and spreading is not dependent 
on the cytoplasmic domain of the core protein, as mu- 
tants expressing core proteins with cytoplasmic dele- 
tions maintain the ability to spread. The spreading is 
mediated through engagement of the syndecan-1 core 
protein, as the Raji-S1 cells also bind to and spread on 
immobilized mAb 281.2, an antibody specific for the 
ectodomain of the syndecan-1 core protein. Spreading 
on the antibody is independent of the heparan sulfate 
glycosaminoglycan  chains and can be inhibited by com- 
petition with soluble mAb 281.2. The spreading can be 
inhibited by treatment with cytochalasin D or colchi- 
cine. These data suggest that the core protein of synde- 
can-1 mediates spreading through the formation of a 
multimolecular signaling complex at the cell surface 
that signals cytoskeleton reorganization. This complex 
may form via intramembrane or extracellular interac- 
tions with the syndecan core protein. 
S 
YNDECAN-1, an integral membrane cell surface pro- 
teoglycan initially  described  on  mouse  mammary 
epithelial cells (Rapraeger et al.,  1985; Rapraeger 
and Bernfield, 1983; Saunders et al., 1989), is the first char- 
acterized member  of a  syndecan family,  which  also  in- 
cludes  syndecan-2  (fibroglycan)  (Marynen et  al.,  1989; 
Pierce et al., 1992), syndecan-3 (N-syndecan)  (Carey et al., 
1992; Gould et al.,  1992), and syndecan-4  (ryudocan or 
amphiglycan) (David et al., 1992; Kojima et al., 1992). The 
unifying features of this family are their highly conserved 
transmembrane and cytoplasmic domains, and the pres- 
ence of heparan sulfate glycosaminoglycan chains on their 
ectodomains. Most cells express  at least one member of 
the syndecan family. However, many cells express  more 
than  one  member,  suggesting  that  each  syndecan may 
have  specific  functions at  the  cell  surface  (Kim et  al., 
1994). The syndecans are proposed to have roles in growth 
factor action, extracellular matrix adhesion, and cytoskele- 
ton organization that controls cell morphology (for review 
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see Bernfield et al., 1992; Jalkanen et al., 1992; Rapraeger, 
1993). 
Although syndecan-1  is expressed  by a variety of cell 
types, it is most prevalent on epithelia (Kim et al., 1994). It 
is on the entire surface of cells in transitional or stratified 
epithelia, but is confined to the basolateral cell borders of 
simple  epithelia (Rapraeger et al.,  1986; Sanderson and 
Bernfield, 1988), suggesting its participation in cell adhe- 
sion mechanisms.  This role is also suggested during early 
development of the mouse, where syndecan-1 is localized 
to sites  of cell-cell contact  beginning  at  the  blastocyst 
stage (Sutherland et al., 1991). This role is also suggested 
by the binding of syndecan-1 to a variety of matrix macro- 
molecules via its heparan sulfate glycosaminoglycan chains, 
including interstitial collagens (Koda et al., 1985; Ridley et 
al., 1993), fibronectin (Saunders and Bernfield, 1988), ten- 
ascin (Salmivirta et al., 1991), and thrombospondin (Sun et 
al., 1989). 
Syndecan-1 is also expressed  within the B cell lineage. 
The proteoglycan is found on precursor B cells in the bone 
marrow, but is absent from B cells that are released from 
the marrow into circulation. Syndecan-1 is expressed once 
again, however, when these cells differentiate into plasma 
cells (Sanderson et al., 1989). It has been suggested  that 
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mobilize them within the extracellular matrix; syndecan-1 
expressed  on plasma cells or on syndecan-1 transfected 
ARH-77 B cells has been shown to bind collagen (Ridley 
et al., 1993; Sanderson et al., 1992) and prevents B cell in- 
vasion of collagen matrices (Liebersbach and Sanderson, 
1994). Expression of syndecans 1 and 4 in ARH-77 lym- 
phoid cells also causes cell-cell aggregation in a calcium- 
and  heparan  sulfate-dependent  heterotypic  interaction 
(Stanley et al., 1995). 
Several investigators have questioned the role of synde- 
can-1  by manipulating its expression level. Expression of 
exogenous syndecan-1 cDNA in rat Schwann cells causes 
the  cells to spread  more  extensively on fibronectin and 
laminin (Carey et al.,  1994a)  and to  form an  increased 
number of focal adhesions (Hansen et al., 1994). Overex- 
pression of syndecan-1 in 293T renal epithelial cells causes 
the cells to become more anchorage dependent and less 
motile, with an increase in serum-dependent proliferation 
and a decreased proliferation rate in the absence of serum 
(Numa et al., 1995). Overexpression of syndecan-1 in NIH 
3T3 fibroblasts also causes a morphological transition, and 
the  cells become  less  responsive  to  basic FGF  (bFGF) 
(Elenius et al., 1992). 
There are several examples of the importance of synde- 
can-1 in epithelial morphogenesis. However, relatively little 
is known about its mechanism of action. In early develop- 
ment, syndecan-1 is expressed at sites of epithelial-mesen- 
chymal interactions (Boutin et al.,  1991; Thesleff et  al., 
1988; Trautman et al., 1991; Vainio et al., 1989a, b) and is 
reportedly downregulated on epithelia during epithelial- 
mesenchymal transformation (Bernfield et  al.,  1992).  A 
similar conversion is noted in cell culture. When syndecan-1 
expression  is  reduced  by  antisense  RNA  in  NMuMG 
mouse mammary epithelial cells, the cells downregulate 
E-cadherin, redistribute [31 integrins, and convert to a fusi- 
form morphology (Kato et al., 1995). This suggests a cru- 
cial role for syndecan-1 in the maintenance of epithelial 
morphology. Interestingly, the heparan sulfate chains of 
syndecan-1 do not appear to be required for this activity, 
nor is it clear which domains of the core protein have an 
important role.  In  another  example,  treatment of $115 
mammary epithelial cells with steroids causes a reduction 
in syndecan-1 expression that is accompanied by conver- 
sion to a fusiform morphology. If syndecan-1 expression is 
maintained  by  transfection  of  an  exogenous  syndecan 
gene, the cells retain their epithelial morphology (Lepp~i 
et al., 1992).  In this example, however, the activity is de- 
pendent upon the heparan sulfate chains of the extracellu- 
lar domain and does not appear to require either the cyto- 
plasmic or transmembrane  domains of the core protein 
(Mall et al., 1994). 
This suggests that each of the domains of the syndecan 
core  protein  may have  individual roles.  In  syndecan-1- 
expressing rat Schwann cells, antibody-induced clustering 
of the proteoglycan causes cocapping with actin filaments. 
This cocapping is dependent on the cytoplasmic domain of 
the core protein of syndecan-1 (Carey et al., 1994b).  Al- 
though this recognition is demonstrated for syndecan-1, it 
is not clear whether other syndecans would behave identi- 
cally. For example, syndecan-4 is localized to focal adhe- 
sions in a variety of cell types, whereas syndecan-2 on the 
same cells is not localized to these structures (Woods and 
Couchman, 1994). 
Increasing evidence suggests that cell surface proteogly- 
cans collaborate in activating intracellular signaling path- 
ways. Fibroblasts plated on fibronectin require both the 
engagement of cell surface proteoglycans and integrins to 
spread  fully,  forming  focal  contacts  and  stress  fibers 
(Woods et al.,  1986).  The requirement for proteoglycan 
engagement can be overcome, however, by treatment of 
the cells with phorbol ester (Woods and Couchman, 1994), 
suggesting that the engagement of the proteoglycan gener- 
ates a signal to establish the fully spread phenotype. This 
signal can be negated by inhibitors of protein kinase C. 
Similarly, expression of collagenase by fibroblasts plated 
on fibronectin is regulated by proteoglycan engagement, 
acting together with integrins that recognize the fibronec- 
tin cell binding domain (Tremble et al., 1994; Werb et al., 
1989). The chondroitin-sulfate proteoglycan NG2 also col- 
laborates with 0t4131 integrin to promote cell spreading and 
focal contact formation (Iida et al., 1995). In this system, 
the proteoglycan and the integrin can be triggered inde- 
pendently to generate the spreading signal, suggesting that 
the proteoglycan itself can assemble a signaling complex 
to generate a signal that it has been engaged. 
One  difficulty in studying specific roles for individual 
proteoglycans is that cells usually express more than one 
type, making it difficult to determine the role of a particu- 
lar proteoglycan. In the present work, we examine human 
Raji cells transfected with the cDNA for a single cell sur- 
face proteoglycan, namely syndecan-1. Raji cells (Pulver- 
taft, 1965) were chosen for this study because they have 
tested negative for syndecan-1 by Northern and immuno- 
detection analysis and for cell surface heparan sulfate by 
their failure to bind ligands with heparin-binding domains, 
such as bFGF (data not shown). We have obtained cell 
populations expressing high levels of syndecan-1 and trun- 
cated variants of this molecule to study its interactions at 
the cell surface and its role in cytoskeleton assembly and 
cell spreading. 
Materials and Methods 
cDNA Constructs 
Mouse  syndecan-1  cDNA  (Saunders  et  al.,  1989)  was  cleaved  from 
pGEM3Z-Syndecan-1 (4-19b), generously provided by Dr. Merton Bern- 
field (Joint Program in Neonatology, Harvard Medical School,  Boston, 
MA), and inserted into plasmid 636, generously provided by Dr. Bill Sug- 
den (McArdle Laboratory, University of Wisconsin,  Madison, WI). The 
636 plasmid contains genes conferring hygromycin resistance for selection 
in mammalian cells and ampicillin resistance for selection in bacteria. It 
also contains the origin of plasmid replication, ori P, of the Epstein-Barr 
Virus (EBV)  1 to generate a high copy number of plasmids in EBV-posi- 
tive transfected cells  (Sugden et al.,  1985). To generate p636syndl-FL, 
syndecan cDNA was cleaved from pGEM3Z-Syndecan-1 with EcoRl and 
HindlIl (New England Biolabs, Inc., Beverly, MA); HindlII linkers (New 
England Biolabs, Inc.) were ligated using T4 DNA ligase (New England 
Biolabs, Inc.), trimmed with HindlII, and the resulting syndecan-1  cDNA 
was subeloned into the unique Hindlll site in 636. This construct encodes 
full-length syndecan-1 protein. 
The plasmid p636syndl-A12  was generated by cleaving p636syndl-FL 
with BanI, truncating the cytoplasmic domain at nucleotide 1131. A linker 
1. Abbreviations used in this paper: CMF-PBS,  calcium- and magnesium- 
free PBS; EBV, Epstein-Barr virus; Hb-DME, Hepes-buffered DME. 
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the fragment. This insert was subcloned into parental 636 via its HindlII 
and NheI cloning sites. This construct encodes a core protein truncated af- 
ter amino acid 299. 
The plasmid p636syndl-A33 was generated by cleaving pGEM7zf+- 
syndl-FL (Promega Corp., Madison, WI) with BsaW1, which cleaves syn- 
decan-1 cDNA to truncate the cytoplasmic domain at nucleotide 1069. A 
linker encoding a stop codon and an NheI cloning site was ligated to the 
ends, and this fragment was cleaved with NheI and XhoI. The insert was 
cloned into p636synd-l-FL, which had been cleaved with Xhof and NheI. 
Xhof cleaves mouse syndecan-1 cDNA at nucleotide 105 in the 5' untrans- 
lated region. This construct encodes a  core protein truncated at amino 
acid 280 (which is converted from methionine to glycine) due to the inser- 
tion of a stop codon. All constructs were analyzed for correct orientation 
by restriction enzyme mapping and confirmed by sequence analysis using 
the dideoxy-mediated chain-termination method (Sanger et al., 1977) with 
Sequenase version 2.0 (United States Biochemical Corp., Cleveland, OH). 
Cell Culture 
The human Raji cell line is an EBV-positive Burkitt's lymphoma cell that 
expresses the Epstein-Barr nuclear antigen 1, which is necessary and suffi- 
cient for latent replication of DNA containing the EBV ori P site of repli- 
cation (Reisman and Sugden, 1986). Raji cells were grown in RPMI 1640 
(Gibco Laboratories, Gaithersburg, MD) supplemented with 10% calf se- 
rum (Hyclone Laboratories, Logan, UT). Low passage NMuMG mouse 
mammary epithelial cells were grown as previously described (David and 
Bernfield, 1979)  in DME (Gibco Laboratories) supplemented with 10% 
calf serum (Hyclone Laboratories). 
Plasmid DNA was introduced into parental Raji cells by electropora- 
tion (Neumann et al., 1982),  and transfected cells were selected by growth 
in hygromycin-B (300 p.g/ml).  High expressing transfectants were selected 
further by panning on mAb 281.2.  Briefly, mAb 281.2 (50-250 p,g/ml) or 
control rat IgG was incubated at 4°C overnight in Hepes-buffered DME 
(Hb-DME),  pH  7.4,  on  35-cm  2 tissue-culture dishes. The  dishes were 
washed three times with Hb-DME, and transfected cells were plated in 
RPMI 1640 containing 10% calf serum. After incubating 2 h at 37°C, non- 
adherent cells were aspirated, and the plates were rinsed three times in 
RPMI containing 10% calf serum. Medium was changed on day 3, and the 
adherent cells were harvested by treatment with trypsin (0.25%) at 37°C 
on day 5, followed by growth in suspension. 
Antibodies 
Two antibodies were  used to  detect  syndecan-l: (a)  a  rat  monoclonal 
IgG2A (mAb 281.2) specific for the ectodomain of syndecan-1 (Jalkanen 
et al., 1985) and (b) an affinity-purified antiserum (S1CD) to the carboxyl- 
terminal 10 amino acids of the cytoplasmic domain. Control antibodies for 
spreading assays and immunofluorescence included rat IgG (Jackson Lab- 
oratories,  West Grove,  PA),  anti-human IgM  (Jackson  Laboratories), 
anti-thyl.1,  a  rat IgG2  A purified  from hybridoma (M5/49.4.1;  obtained 
from the American Type Culture Collection,  Rockville, MD)  superna- 
tants in the same manner as mAb 281.2, and preimmunization serum from 
the rabbit injected to produce the SICD antibody. 
Gel Electrophoresis  and lmmunoblotting  of Syndecan-1 
Whole cells were lysed and sonified in 8 M  Urea, 0.1% Triton X-100, 10 
mM Tris, 1 mM Na2SO4, pH 8.0. DEAE-Sephacel (Pharmacia LKB, Upp- 
sala, Sweden) was added to the lysate (100 p.l per 107 cells) and mixed 
overnight at 4°C. Proteoglycans were eluted from the DEAE beads with 
1 M  NaCI in heparitinase buffer as described (Yeaman and Rapraeger, 
1993).  Enzymatic cleavage  of heparan  sulfate  and  chondroitin  sulfate 
chains was accomplished by diluting samples twice with dH20 followed by 
incubation twice for 2 h  at 37°C with either heparitinase III  (0.2 U/ml), 
chondroitin  ABC  lyase  (0.05  U/ml)  (ICN  Nutritional  Biochemicals, 
Cleveland, OH), or with both enzymes. The samples were fractionated by 
electrophoresis,  electrotrophoretically  transferred  onto  cationic  mem- 
brane  (Zeta-Probe-GT;  Bio-Rad  Laboratories,  Hercules,  CA),  and 
probed with mAb 281.2 orS1CD as previously described (Yeaman and 
Rapraeger, 1993). 
Preparation of  Protein-coated Surfaces 
Nitrocellulose-coated  tissue-culture dishes were  prepared  as  described 
(Lagenaur and Lemmon, 1987).  Briefly, 5 cm  2 of nitrocellulose was dis- 
solved in 6  ml 100%  methanol overnight and applied to tissue-culture 
plasticware. The methanol was allowed to evaporate under UV light in a 
laminar flow hood for 30 min, and the coated surfaces were washed and 
incubated with dH20 for 15 rain. On a 2-era  / surface, 100 I~l human throm- 
bospondin (75 Izg/ml), mAb 281.2 (250 I~g/ml), or rat IgG (250 Ixg/ml) was 
applied to the nitrocellulose in Hb-DME, pH 7.4, for 30 rain at room tem- 
perature.  Human  thrombospondin  was  generously  provided  by  Drs. 
Vishva Dixit (Department of Pathology, University of Michigan, Ann Ar- 
bor, MI) and Deane Mosher (Department of Medicine, University of Wis- 
consin, Madison, WI). The protein solution was then aspirated. The wells 
were washed twice with dH20 followed by Hb-DME and then blocked with 
1% BSA in Hb-DME for i  h at 37°C. Proteins were also bound directly to 
tissue-culture dishes or glass coverslips without nitrocellulose coating by 
incubation at 4°C overnight at concentrations ranging from 10 p~g/ml to 
250 t~g,/ml. They were then washed and blocked in the same manner as 
above. Plates and coverslips were blocked with either 1% heat-denatured 
BSA or 10% calf serum. 
Fibronectin and fibronectin fragments (50-100 p.g/ml) (generous gifts 
of Dr. Donna P. Peters, Department of Pathology and Laboratory Medi- 
cine, University of Wisconsin, Madison, WI) were bound to glass cover- 
slips at 37°C for 2 h, washed four times with Hb-DME, and then blocked 
for 2  h  at 37°C with 1%  heat-denatured BSA in Hb-DME.  Cells were 
plated in the same solution. 
lmmunocytochemistry 
For detection of syndecan-1 in fixed cells, cells were plated onto protein- 
coated coverslips in 1% BSA/Hb-RPMI or in RPMI 1640 including 10% 
calf serum, incubated 2 h at 37°C, and then fixed for 2 h via the periodate- 
lysine-paraformaldehyde method (2%  paraformaldehyde, 0.1  M  lysine, 
0.01 M  sodium periodate) (McLean and Nakane, 1974).  Fixed cells were 
washed twice in 0.05% sodium borohydride and were incubated 30 rain in 
0.1  M  glycine in calcium- and magnesium-free PBS (CMF-PBS) at 4°C. 
Cells were permeablized with 0.2% Triton X-100 in PBS for 3 rain and in- 
cubated for 3  x  10 min in CMF-PBS containing 10% FBS to reduce non- 
specific binding. Primary antibody (5 p,g/ml for S1CD) was incubated in 
CMF-PBS containing 10% FBS for 30 min. Ceils were washed thoroughly 
and then incubated with secondary antibody (goat anti-rabbit fluorescein- 
conjugated IgG)  (Jackson Laboratories)  used at 25 I~g/ml in CMF-PBS 
containing 10% FBS for 30 rain. Rhodamine-conjugated phalloidin (Mo- 
lecular Probes, Inc., Eugene, OR), was used at a  dilution of 1:40 during 
the secondary antibody incubation. Cells were washed 10 rain in CMF- 
PBS containing 10% FBS and then three times in CMF-PBS. Coverslips 
were mounted onto glass slides in phosphate-buffered glycerol containing 
1 mg/ml p-phenylenediamine as an anti-photobleaching agent and viewed 
on a microscope (Microphot-FX; Nikon Inc., Garden City, NY). Pictures 
were recorded on film (Tri-X Pan 400; Eastman-Kodak Co., Rochester, 
NY) exposed at ASA 800. 
Spreading Assays 
Cells were plated on protein-coated surfaces in Hb-DME, pH 7.4, contain- 
ing 1% BSA and were incubated for 2 h at 37°C. The percentage of spread 
cells was then determined by counting total cells vs. spread cells in three 
1-cm  2 areas present in each of the duplicate or triplicate wells. A  spread 
cell was defined as one having at least one filopodium visible at a magnifi- 
cation of 25 and was less refractive than unspread cells. 
Glycosaminoglycan  chains were removed from the cell surface by enzy- 
matic cleavage. Cells were pretreated for 30 min with 0.2 U/ml hepariti- 
nase III, 0.05 U/ml chondroitin ABC lyase, or both enzymes, and plated in 
the spreading assay in the continued presence of these enzymes. 
Cells were preincubated for 1 h at 37°C in either 10 p,M cytochalasin D 
(Sigma Chemical Co., St. Louis, MO) or 50 ~M colchicine (Sigma Chemi- 
cal Co.) in Hb-DME containing 1% BSA. Cells were pretreated with cy- 
cloheximide (25 p,g/ml) for 2 h before plating. Inhibition of protein syn- 
thesis was monitored by Tran3SS-label (ICN Pharmaceuticals, Inc., Irvinc, 
CA) labeling into TCA-precipitablc fractions of cells after a 2-h preincu- 
bation period. All cells were plated in the spreading assays in the contin- 
ued presence of the inhibitors. Each assay was repeated  at least three 
times. 
Antibody Inhibition of Cell Spreading 
Cells were plated on mAb 281.2 in RPMI 1640 containing 10% calf serum. 
After 10 min, unbound cells were aspirated, and bound cells washed with 
Lebakken and Rapraeger Syndecan-1  Mediates Cell Spreading  1211 medium. Competing  antibodies, mAb 281.2 or nonspeeific rat IgG,  were 
added to the medium at 100 ixg/ml. The cells  were incubated at 37°C for 
2 h, and the percentage  of spread ceils  determined. Alternatively,  the cells 
were incubated for 2 h at 37°C before addition of competing antibody. 
The cells were washed three times, and mAb 281.2 was added at concen- 
trations of 10 p.g/ml  and 100 ~g/ml. Rat IgG was added to control wells at 
100 Ixg/ml.  After incubating 4 h at 37°C, the cells were counted and the 
percent spread determined. 
Results 
Expression  of Syndecan-I in Human Raft Cells 
The Raji  cell line  transfected with the  eDNA for synde- 
can-1 is  a  good candidate  for exploring roles of this  cell 
surface proteoglycan. The parental cells (a) contain little 
or no cell surface heparan sulfate, assessed by the failure 
to bind ligands such as bFGF and thrombospondin, (b) are 
negative  for  syndecan-1  mRNA,  assessed  by  Northern 
analysis (data not shown), and (c) are negative for synde- 
can-1  protein, assessed by immunoblotting analysis  (Fig. 
1).  Thus,  transfection  of Raji  cells with the  636  plasmid 
containing  the  mouse syndecan-1  eDNA, which  is  repli- 
cated at high levels in these cells (see Materials and Meth- 
ods), allows high level expression of the syndecan-1  core 
protein and analysis of whether or not any changes in cell 
behavior accompany this expression. 
Cells were transfected with the plasmid p636-Syndl-FL 
and selected by resistance to hygromycin B. Hygromycin- 
resistant cells were further  selected by panning on mAb 
281.2,  a  syndecan-l-specific mAb. These cells were con- 
firmed to be a population of cells expressing high levels of 
Figure 1.  Expression  of syndecan-I in Raji cells transfected with 
p636-Synd1-FL.  Syndecan-1  was  batch  adsorbed  to  DEAE 
Sephacel from lysates of Raji parental cells or Raji-S1 cells trans- 
fected with p636-Syndl-FL.  NMuMG mouse mammary epithelial 
cells, known to express syndecan-1, are shown as a positive con- 
trol.  Proteoglycans  were isolated as described  in Materials  and 
Methods.  Samples  were  electrophoresed  on  a  3.5-15%  Tris- 
borate SDS-polyacrylamide gradient gel (2.5 million cell equiva- 
lents  per lane) after digestion  without or with  heparitinase III 
(Hep'ase), or heparitinase  III together with  chondroitin  ABC 
lyase (Chon'ase). The gel was electrophoretically  transferred to 
Zeta Probe-GT cationic membrane, which was then probed with 
mAb 281.2, as described  in Materials  and Methods.  Protein mo- 
lecular weight standards  are indicated (left) in kD. 
heparan  sulfate--decorated  syndecan-1  by  immunoblot 
analysis with mAb 281.2 (Fig. 1). The syndecan-l-express- 
ing  cells (Raji-S1)  are compared to parental cells  (Raji) 
and to NMuMG epithelial cells that are known to express 
cell surface syndecan-1. The parental Raji cells are nega- 
tive for syndecan-1 protein, whereas the Raji-S1 cells con- 
tain immunoreactive proteoglycan that runs  in  a  hetero- 
disperse distribution on polyacrylamide gels with a modal 
molecular weight of 134,000.  This is smaller than the form 
detected in NMuMG cells, which has a  modal molecular 
weight of 198,000.  The level of expression in these cells is 
similar to that of the NMuMG cells, which are known to 
express abundant levels of syndecan-1. 
Decoration  of  the  syndecan-1  core  protein  with  gly- 
cosaminoglycan chains was analyzed by digestion with he- 
paritinase III, which  specifically cleaves heparan sulfate, 
and  chondroitin  ABC  lyase,  which  specifically  cleaves 
chondroitin  sulfate. Syndecan-1 expressed by the Raji-S1 
cells is  largely decorated  with  heparan  sulfate,  as  treat- 
ment with heparitinase III reduces the size of the proteo- 
glycan to ~80 kD. The proteoglycan may also be decorated 
with minor  amounts  of chondroitin  sulfate as  additional 
reduction in size is seen if the heparitinase is augmented 
with chondroitin ABC lyase. This size and composition is 
consistent with syndecan-1 expressed as a heparan sulfate 
proteoglycan in  B  lymphocytes (Sanderson  et  al.,  1989). 
The Raji-S1 cells may also be producing core protein that 
does not contain glycosaminoglycan chains, as staining is 
seen at 80 kD even in the absence of enzyme treatment. 
Syndecan-1  Transfected  Raft Cells Bind to and Spread 
on Thrombospondin  and Fibronectin 
To examine the potential influence of syndecan-1  on cell 
attachment,  the  Raji-S1  cells  were  plated  on  thrombo- 
spondin, a ligand for the heparan sulfate chains of synde- 
can-1 (Sun et al., 1989). The Raji parental cells fail to bind 
to  thrombospondin  (Fig.  2  A).  However, as  anticipated, 
the  Raji-S1  cells bind to  the  ligand.  The  binding  occurs 
within 5  min of plating and  involves the  majority of the 
plated  cells.  In addition  to binding  the  thrombospondin, 
however, the cells also spread on this ligand and acquire a 
bipolar morphology when fully spread (Fig. 2 B). 
To test the ability of Raji-S1 cells to spread on another 
syndecan-1  ligand,  Raji  cells were  plated  on  fibronectin 
(Saunders and Bernfield, 1988). In contrast to the results 
observed  with  thrombospondin,  the  Raji  parental  cells 
bind to fibronectin in the absence of syndecan-1, although 
only a small percentage of the cells (~10%) spread on this 
ligand (Fig. 2 C). This suggests that the Raji parental cells 
express a cell adhesion molecule, presumably an integrin, 
that binds to fibronectin. When compared to the parental 
cells, however, a  much greater proportion of the Raji-S1 
cells spread and to a much greater extent (Fig. 2 D). The 
additional spreading response appears due to the binding 
of heparan sulfate on syndecan-1  to the heparin-binding 
domain of the fibronectin because only a small percentage 
of the  Raji-S1  cells spread if plated on a  fragment of fi- 
bronectin lacking this domain (data not shown). The cells 
behave identically to parental cells that are plated either 
on intact fibronectin (Fig. 2 C) or on the fragment with the 
heparin-binding domain removed (data not shown). 
The Journal of Cell Biology,  Volume 132, 1996  1212 Figure 2.  Binding and spreading of Raji parental and Raji-S1 ceils on thrombospondin and fibronectin.  Raji parental cells (A and C) 
and Raji-S1 cells (B and D) were plated on glass coverslips coated with 55 p,g/ml  thrombospondin (A and B) or 100 p~g/ml  fibronectin (C 
and D) and blocked with heat-denatured BSA. The cells were incubated at 37°C for 2 h before fixation. Bar, 25 p~m. 
As suggested for fibronectin, the spreading on thrombo- 
spondin  requires  the  heparan  sulfate  glycosaminoglycan 
chains on syndecan-1.  Raji-S1  ceils were pretreated with 
heparitinase III, chondroitin ABC lyase, or both enzymes 
to remove heparan sulfate and/or chondroitin sulfate gly- 
cosaminoglycans before plating on thrombospondin (Fig. 
3 A). Treatment of the Raji-S1 cells with heparitinase re- 
duces their spreading to 4%, similar to that of Raji paren- 
tal  cells  used  as  controls.  This  is  in  contrast  to  the  un- 
treated Raji-S1 cells, of which 86%  are spread within 2 h 
of plating. Treatment with chondroitin ABC lyase is with- 
out effect (87% spread), whereas treatment with the com- 
bined  enzymes is equivalent  to  treatment  with hepariti- 
nase alone (2% spread). 
Spreading of Raji-S1 Cells Occurs Rapidly and Does 
Not Require New Protein Synthesis 
The Raji-S1 cells attach and spread rapidly. Within 20 min 
of plating, 54% of the cells plated on thrombospondin are 
beginning to spread, and 93% of the cells are fully spread 
within 60 min after plating (Fig. 4). These data suggest that 
the cells are binding to the supplied ligand  (in this case, 
thrombospondin), rather than assembling their own extra- 
cellular  matrix.  This  was  further  tested  by  performing 
spreading studies after incubation of the cells in cyclohex- 
imide to block new protein synthesis.  Cells were treated 
with 25 }xg/ml cycloheximide for 2 h, blocking incorpora- 
tion  of [35S]methionine  and  cysteine into  TCA-insotuble 
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Figure 3.  Analysis for the requirement of heparan sulfate chains 
for spreading on thrombospondin or mAb 281.2. Raji-S1  cells 
($1) were pretreated  for 30 min at 37°C with heparitinase  III, 
chondroitin ABC lyase, or both enzymes to selectively remove 
GAG chains at the cell surface.  The cells were plated in 1% BSA 
in  Hb-DME  onto  nitrocellulose-coated  dishes  incubated  with 
thrombospondin (A) or mAb 281.2 (B). Spreading of Raji paren- 
tal cells (P) is shown as a control in each panel. 
material by 88.7% (SE 3.9%). These cells are not inhibited 
in their ability to spread  (91%  spread relative to control, 
untreated cells) (see Fig. 10). 
The Cytoplasmic Domain of Syndecan-1 Is Not 
Required for the Syndecan-l-depeadent Spreading 
The  cytoplasmic  domain  of syndecan-1  has  been  impli- 
cated in its interaction with the cytoskeleton. For example, 
in  Schwann  cells  expressing  full-length  syndecan-1,  anti- 
body-induced capping of syndecan-1  also caps  actin fila- 
ments to these sites, whereas in cells expressing a core pro- 
tein  truncated  in  its  cytoplasmic  domain,  actin  fails  to 
cocap  with  syndecan-1  (Carey  et  al.,  1994b).  To  assess 
whether  the  cytoplasmic domain  of the  syndecan-1  core 
protein is required for the syndecan-l-dependent spread- 
ing observed here, truncation mutants were expressed  in 
Raji parental  cells and assayed for their  ability to spread 
on heparan sulfate ligands. Raji-S1A12 ceils express a form 
of the proteoglycan in which the last 12 amino acids of the 
cytoplasmic domain have  been  deleted.  Raji-S1A33  cells 
express  a  truncated  core  protein  in  which  all  but  one 
amino acid of the cytoplasmic domain has been removed, 
but a second amino acid (glycine) is added, leaving a two-- 
amino  acid cytoplasmic domain.  The  cells  express  these 
truncated  forms  of  syndecan-1  as  heparan  sulfate  pro- 
teoglycans at the cell surface, and they both mediate  cell 
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Figure 4.  Time course of Raji-S1 cell spreading on thrombospon- 
din. Raji-S1 cells (closed  circles) and Raji parental cells (open cir- 
cles) were plated on thrombospondin or BSA-blocked nitrocellu- 
lose  (data  shown  for  Raji-S1  cells;  closed triangles). At  time 
points of 20, 60, and 120 min, the cells were counted, and the per- 
centage spread was determined. A spread cell was defined as one 
having at least one filopodium visible  at x25 magnification and 
was less refractive than unspread cells. 
The glycosaminoglycan chains can be removed enzymati- 
cally to generate a core protein similar in size to that seen 
in the Raji-S1 cells (Fig. 5). These core proteins are immu- 
noreactive with mAb 281.2, but not with a polyclonal anti- 
body  (SICD)  generated  against  the  COOH-terminal  10 
amino acids of the native cytoplasmic domain, confirming 
that  the  COOH  terminus  of the cytoplasmic domain has 
been truncated in these mutants. 
Like the Raji-S1  ceils,  the  Raji-S1~12  and  Raji-S1A33 
Figure 5.  Expression of truncated syndecan-1 in Raji cells. Syn- 
decan-1 was batch adsorbed to DEAE Sephacel from lysates of 
Raji-S1, Raji-S1A12, or Raji-S1A33 cells. Proteoglycans were iso- 
lated as described in Materials and Methods. Samples were elec- 
trophoresed on a 3.5-15% Tris-borate SDS-polyacrylamide gra- 
dient gel (1 million cell equivalents per lane) after digestion with 
heparitinase III and chondroitin ABC lyase. The gel was electro- 
phoretically transferred  to Zeta  Probe-GT cationic membrane 
and probed with either mAb 281.2 (lanes 1) or SICD (lanes 2) as 
described in Materials and Methods. 
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Figure 6.  Spreading of syndecan-1 truncation mutants on throm- 
bospondin.  Raji-S1, Raji-S1A12, Raji-S1A33, and parental cells 
were plated  on glass coverslips  coated with  thrombospondin, 
blocked with heat-denatured BSA, and incubated at 37°C for 2 h 
before fixation. Very few of the parental cells bind to the throm- 
bospondin  (see  Fig. 2), while the majority  of the syndecan-1- 
expressing ceils bind to the thrombospondin and spread.  Rela- 
tively equal proportions of the cells expressing the truncation 
mutants spread, and the morphology of the cells is indistinguish- 
able when compared to the Raji-S1 cells. 
cells  spread  on  thrombospondin  or  fibronectin.  When 
plated on thrombospondin and assayed for the percentage 
of cells spread after 2 h, the cells behave similarly (Fig. 6). 
The  morphology of the  truncation  mutants  is  indistin- 
guishable from that of the cells expressing the intact core 
protein  on  both  thrombospondin  and  fibronectin  (not 
shown).  In  subsequent  assays  tested in  this  manuscript, 
these  truncation  mutants  behaved  similarly to  the  full- 
length syndecan-1 protein. 
Cell Spreading Is Mediated by the Syndecan-1 
Core Protein 
The ability of the Raji-S1A33 cells to spread on heparan 
sulfate ligands suggests that the interactions required for 
spreading in a syndecan-l-dependent manner occur via a 
binding partner(s) present in the membrane or at the cell 
surface. Such interactions have previously been described 
for other proteoglycans. For example, K1735 mouse mela- 
noma cells adhere to fragments of fibronectin via a glypi- 
can-like heparan sulfate proteoglycan (Drake et al., 1992). 
In this case, the heparan sulfate chains of the proteoglycan 
are proposed to mediate initial cell adhesion to fibronec- 
tin, thereby allowing lateral association with other cell ad- 
hesion molecules that stabilize the adhesion and promote 
spreading. The Raji syndecan-l-dependent spreading that 
is observed here may be due to such a mechanism, and if 
so would depend on binding interactions of the heparan 
sulfate chains. Another possibility, however, is that the in- 
teraction is through the core protein directly rather than 
the heparan sulfate chains, presumably via the transmem- 
brane or extracellular domain. 
To determine if the spreading can be triggered by en- 
gagement of the syndecan-1 core protein alone, cell spread- 
ing was  examined  on  mAb  281.2,  which  recognizes an 
epitope  on  the  extracellular  domain  of the  syndecan-1 
core protein.  Cells  were  plated  on  coverslips incubated 
with either mAb 281.2 or nonspecific rat IgG (Fig. 7, A-D) 
and blocked with 1% native BSA in Hb-DME. Whereas 
the  Raji  cells  do  not  bind  nonspecifically to  coverslips 
blocked with denatured BSA, both the parental and Raji- 
S1 cells adsorb when native BSA is used as the blocking 
agent, as has been reported (Ballard et al., 1991). Despite 
their ability to adhere to the coverslip, however, the cells 
fail to spread. Thus, when the native BSA mixture is used 
to block either nonspecific rat IgG or mAb 281.2-coated 
coverslips,  both  the  parental  and  Raji-S1  cells  adhere. 
However, the parental cells do not spread on either anti- 
body. In contrast, the Raji-S1  cells rapidly become fully 
spread on mAb 281.2 but fail to spread on nonspecific rat 
IgG.  Similarly,  both  the  Raji  parental  cells,  which  are 
known to express surface immunoglobulin (Polliack et al., 
1983), and Raji-S1 cells bind to immobilized anti-IgM anti- 
body but fail to spread (data not shown). The adsorption 
of parental and Raji-S1 cells to native BSA-coated or anti- 
IgM--coated coverslips provide important controls for the 
syndecan-l-mediated spreading,  e.g., simple adhesion to 
the substratum is not sufficient for cytoskeletal reorgani- 
zation required for spreading. Rather, adhesion must uti- 
lize a receptor that can initiate reorganization of the cy- 
toskeleton.  In  this  case,  the  syndecan-1  core  protein 
appears to be such a receptor. 
To  verify that  the  cells  were  binding  solely to  mAb 
281.2, and to rule out the contribution of other surface re- 
ceptors such  as  the  molecules that  bind  the  BSA,  cells 
were  plated  on  coverslips  coated  with  mAb  281.2  and 
blocked such that nonspecific binding did not occur. This 
is accomplished either with heat-denatured BSA (Fig. 2 A) 
or 10% calf serum. This abolishes nonspecific binding, and 
adhesion occurs only by the syndecan-1 core protein. As 
expected, the  Raji-S1  cells rapidly bind  to mAb  281.2- 
coated coverslips and spread (Fig. 7 F). These cells fail to 
bind to nonspecific rat IgG (Fig. 7 E). Thus, binding to the 
syndecan-1 core protein alone is sufficient to promote the 
spreading. 
It is important to rule out the contributions of the gly- 
cosaminoglycan chains in the spreading of Raji-S1  cells, 
even on mAb 281.2. Raji-S1 cells were pretreated with he- 
paritinase III, chondroitin ABC lyase, or both enzymes to 
remove  heparan  sulfate  and/or  chondroitin  sulfate  gly- 
cosaminoglycans before plating on mAb 281.2 (see Fig. 3 
B). Spreading of the Raji-S1 cells on mAb 281.2 is inde- 
pendent of the glycosaminoglycan chains attached to the 
core protein. Nearly all of the Raji-S1 cells spread on mAb 
281.2, regardless of digestion of either the heparan sulfate, 
chondroitin sulfate, or both glycosaminoglycans. 
The Morphology of the Raji-S1 Spread Cells Changes 
over Time 
To examine the reorganization of the cytoskeleton more 
closely, the  morphology of the  Raji-S1  cells  spread  on 
mAb 281.2 was examined over time (Fig. 8). Spreading oc- 
curs very rapidly on the antibody; within 5 min, smooth 
lamellipodium formation can be observed (as in Fig. 8, A 
and B). The spreading appears to be a  biphasic process, 
Lebakken and Rapraeger Syndecan- I Mediates Cell Spreading  1215 Figure 7.  Binding and spreading of Raji-S1 cells on mAb 281.2.  Raji parental cells (A and B) or Raji-S1 cells (C-E) were plated on cov- 
erslips coated either with rat IgG (A, C, and E) or mAb 281.2 (B, D, and F). The coverslips in panels A-D were blocked with native 
BSA, whereas coverslips in panels E  and F were blocked with 10% calf serum. The cells were plated and incubated at 37°C for 2 h be- 
fore fixation. Bar, 25 I~m. 
The Journal of Cell Biology, Volume 132, 1996  1216 Figure 8.  Change in morphology over time of the Raji-S1 cells plated on mAb 281.2. Raji-S1 cells were plated on mAb 281.2 and al- 
lowed to spread for either 15 min (A and B), or 2 h (C and D) before fixation. Cells were permeabilized with 0.2% Triton X-100 and 
stained with S1CD polyclonal antiserum (A and C) and rhodamine-conjugated phallodin  (B and D). The cells send out smooth lamelli- 
podia early in the spreading process (A and B), and then progress to a more fully spread, bipolar morphology (C and D). Bars, 7 p~m (A 
and B), 10 Ixm (C and D). 
however,  as  the  cells  acquire  a  more  elongated,  bipolar 
morphology between 30 min and 1 h  after plating (Fig. 8, 
C and D). Many of the cells maintain the lamellipodia af- 
ter the elongation has occurred. The distribution of synde- 
can-1 on these cells was analyzed by staining with an affin- 
ity-purified  rabbit  antiserum  that  recognizes  the  last  10 
amino acids of the syndecan-1 core protein (S1CD).  Syn- 
decan-1 is distributed evenly at the cell surface and is not 
localized to distinct structures, such as focal adhesions or 
stress  fibers.  The  filamentous  actin  in  the  lamellipodia 
(Fig. 8 B) is comprised of an orthogonal array of actin as 
has been described in lamellipodia of other cells (for re- 
view see Condeelis, 1993). 
Syndecan-l-induced Cell Spreading Can Be Inhibited 
by mAb 281.2 
To  further  demonstrate  that  cell  spreading  is  mediated 
solely by the binding of the syndecan-1 core protein to im- 
mobilized mAb 281.2,  competing concentrations  of solu- 
ble antibody were used in an attempt to inhibit the spread- 
ing  process.  Raji-S1  cells  were  plated  on  tissue-culture 
wells  coated  with  mAb  281.2,  allowed  to  adhere  for  10 
min, and then the wells were washed with Hb-DME to re- 
move  nonadherent  cells.  When  medium  containing  100 
ixg/ml mAb 281.2 is added to the wells, cell spreading over 
a 2-h period is reduced (16%) compared to 100 ~g/ml non- 
specific rat IgG (89%), or in the absence of competing an- 
tibody (91%) (Fig. 9 A). This competition by the antibody 
is specific for the interaction of the core protein with mAb 
281.2 because the attachment and spreading of the cell on 
thrombospondin is not disrupted by 100-1~g/ml concentra- 
tions of the antibody (data not shown). Additionally, cells 
that  are  already spread on mAb 281.2  become rounded 
when exposed to competing amounts of mAb 281.2  and 
lose  adherence  to the  dish.  After 4  h,  the  percentage of 
spread cells is reduced to 42% in 10 i~g/ml mAb 281.2, and 
to  8%  in  100  ixg/ml  mAb 281.2  (Fig.  9  B).  In contrast, 
>90% of the cells remain spread in 100 ixg/ml nonspecific 
rat IgG. This suggests that even 6 h after plating, the Raji- 
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Figure 9.  Inhibition of syndecan-1 induced cell spreading by solu- 
ble mAb 281.2. Raji-S1 cells were plated onto tissue-culture  wells 
coated with mAb 281.2. (A) 10 min after plating, the wells were 
washed three times with Hb-DME, removing nonadherent cells. 
Cells bound to the antibody remained but were not yet spread. 
Medium was added containing antibodies  to compete for binding 
sites:  no  competing antibody (open bar), 100  txg/ml rat  IgG 
(hatched bar), or 100 p,g/ml  mAb 281.2 (double-hatched  bar). The 
cells were incubated 2 h  at 37°C at which time the cells were 
counted, and the percentage of spread cells determined. (B) Raji- 
S1 cells were plated on mAb281.2  as above. The cells were al- 
lowed to adhere and spread 2 h at 37°C at which time the wells 
were washed  three times with Hb-DME. Competing antibodies 
were then added: 100 i~g/ml rat IgG (hatched bar), 10 g,g/ml mAb 
281.2, or 100 ~g/ml mAb 281.2 (double-hatched bars). The cells 
were incubated 4 h in the presence of these competing antibodies. 
After 4 h, the cells were counted,  and the percentage that re- 
mained spread was determined. 
S1 cells are adhering solely to the substratum through the 
interaction of mAb 281.2 and the syndecan-1 core protein. 
The Raji-S1 cells also bind to and spread on Fab fragments 
of mAb 281.2,  demonstrating that the binding is specific 
for the Fab rather than the Fc portion of the antibody. The 
mAb 281.2 Fab fragments also compete for spreading on 
the bivalent mAb 281.2  (data not shown), demonstrating 
that the Fab is acting to compete with protein binding to 
the antibody rather than clustering or otherwise disarrang- 
ing the proteoglycan on the cell surface. 
IntraceUular Signaling Is Required for the 
Syndecan-dependent Spreading 
Cell spreading is a response to signals initiating the reorga- 
nization  of the  cytoskeleton.  To determine  whether  the 
observed spreading is dependent on the polymerization of 
either actin filaments or microtubules, Raji-S1  cells were 
pretreated for 1 h  and plated on glass coverslips coated 
with mAb 281.2 in the presence of 50 IxM colchicine or 10 
I~M cytochalasin D, respectively. Compared to untreated 
cells, cell spreading is drastically inhibited in cells treated 
with either colchicine or cytochalasin D  (96 and 93% inhi- 
bition, respectively) (Fig. 10). The cells recover and spread 
if the drugs are removed (data not shown). The inability of 
these cells to spread is not due to a loss of syndecan-1 at 
the cell surface, as the cells bind the antibody and remain 
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Figure 10.  Analysis  of syndecan-1  induced  spreading in colchi- 
cine, cytochalasin D, and cycloheximide.  Raji-S1 cells were pre- 
treated with 10 p,M cytochalasin.D, 50 p.M colchicine, or 25 p~g/ml 
cycloheximide and plated onto tissue-culture  plastic coated with 
mAb 281.2 in the continued presence of the inhibitors  and incu- 
bated for 2 h at 37°C. The cells were then counted, and the per- 
centage of spread cells determined. This graph represents nor- 
malized results of three independent experiments for each of the 
inhibitors (control, untreated samples set at 100%). 
syndecan-1  is still present  at the  surface of the  rounded 
cells (data not shown). 
Discussion 
The present study examines changes in cell behavior due 
to the acquisition of cell surface syndecan-1. Raji cells ex- 
pressing mouse syndecan-1 bind to fibronectin or throm- 
bospondin,  ligands for the heparan sulfate chains  of the 
proteoglycan, and spread. This spreading does not appear 
to be dependent on the cytoplasmic domain of syndecan-1, 
as cells expressing a truncation mutant lacking all but one 
amino  acid  of the  cytoplasmic domain  also  bind  to  and 
spread on these ligands. This suggests that a signaling com- 
plex is being formed at the membrane by engagement of 
syndecan-1. Formation of this complex is mediated by the 
core protein of the proteoglycan, as spreading occurs on 
mAb 281.2  in  the  absence  of glycosaminoglycan chains. 
Soluble mAb 281.2 blocks the spreading on the antibody 
and induces rounding and detachment of cells that are al- 
ready spread. The spreading is dependent on intracellular 
signaling mechanisms regulating  the  cytoskeleton as cell 
spreading is inhibited by treatment with cytochalasin D  or 
colchicine.  These  data  suggest  that  syndecan-1  is  acting 
through a multimolecular complex at the cell surface to in- 
duce the signaling events required for spreading. 
The  syndecan-l-mediated  adhesion  and  spreading  is 
dependent on the engagement of the core protein of the 
proteoglycan.  This  engagement  can  be  achieved  by the 
binding of the glycosaminoglycan chains to immobilized li- 
gands for heparan sulfate, or through the direct immobili- 
zation of the core protein by binding to mAb 281.2.  When 
the  cells  are  plated  on  ligands  for  the  heparan  sulfate 
chains, the contributions of other cell adhesion molecules, 
such as integrins that are known to bind to these ligands, 
must also be considered. For example, it is likely that the 
parental cells' ability to bind to fibronectin is due to the 
binding of an integrin, of which two candidates are the ~41~1 
(VLA-4)  or  t~3~  1 (VLA-3)  (Takada  et  al.,  1987,  1988; 
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present on the Raji cells (Ballard et al., 1991). Analysis of 
the spreading using mAb 281.2,  a substratum specific for 
the core protein of syndecan-1, avoids this potential com- 
plication  and  demonstrates  that  cell  spreading  is  seen 
when  adhesion  is  accomplished  solely by the  syndecan 
core protein. Syndecan-1 remains the primary means of at- 
tachment  even  6  h  after plating,  as  soluble,  competing 
mAb 281.2 can cause rounding and detachment of fully 
spread cells at this time. Spreading on the antibody also 
allows demonstration that spreading is independent of the 
syndecan-1  glycosaminoglycan chains,  which  can  be  re- 
moved by enzymatic treatment without effect on the adhe- 
sion or spreading response. This is an important observa- 
tion,  as  it rules  out  the  notion  that  the  heparan  sulfate 
chains serve to aggregate syndecan-1 and other receptors 
into a signaling complex. 
Adhesion alone does not induce spreading; rather, a sig- 
nal must be generated to initiate the reorganization of the 
cytoskeleton required for spreading. There are a number 
of examples of this in other cells. Melanoma cells plated 
on anti-133 integrin antibody adhere and spread. However, 
mutations within the cytoplasmic domain of ~33, which do 
not affect adhesion to the antibody, disrupt spreading (Fi- 
lardo et al., 1995). Similarly, K562 leukocytes transfected 
with CD21 bind avidly to complement ligand C3bi but fail 
to  spread.  However, transfection with  aM132, which  also 
promotes efficient binding to C3bi, leads additionally to 
spreading and intracellular phosphorylation events (Gra- 
ham  et  al.,  1994).  In  this  study, we  find  that  Raji  cells 
strongly  adhere  to  nondenatured  BSA-coated plates  or 
coverslips, (see also Ballard et al., 1991) but do not spread. 
Nonetheless,  if  given  an  appropriate  stimulus  such  as 
treatment with phorbol esters, Raji cells do have the ca- 
pacity.~to spread on this substratum; PMA-stimulated cells 
become activated, exhibiting ruffled membranes  and en- 
hanced microspikes. The PMA-induced response can be 
inhibited by 100 nM staurosporin, an inhibitor of protein 
kinase  C.  The PMA-activated cells fail, however, to ex- 
hibit  smooth  lamellipodia  or the  bipolar phenotype ob- 
served on syndecan-1 ligands. Also, the syndecan-l-medi- 
ated  spreading  does  not  appear  to  be  dependent  on 
protein  kinase  C  activity,  as  treatment  of Raji-S1  cells 
plated on mAb 281.2 is not inhibited by staurosporin (data 
not shown). 
A primary response to the engagement of the syndecan-1 
core protein is the rearrangement of the cytoskeleton re- 
quired for spreading to occur. This response is tightly reg- 
ulated by second messengers that stimulate the severing of 
existing actin filaments, polymerization of G- into F-actin, 
and the cross-linking and bundling of actin filaments (for 
review see Stossel, 1989). The syndecan-l-dependent spread- 
ing is inhibited by treatment of the cells with cytochalasin 
D, which blocks actin polymerization. It is also blocked by 
colchicine, which blocks microtubule polymerization. This 
is an unexpected result, as microtubule extension is not re- 
ported to be required for cytoskeletal assembly associated 
with  cell  spreading  (Arkett  et  al.,  1994,  and  others). 
Rather, microtubules have a role in the distribution and 
movement of intracellular organelles and vesicles. For ex- 
ample, pseudopodial activity is decreased in migrating fi- 
broblasts treated with colcemid (Bershadsky et al.,  1991); 
presumably, microtubules are required to transport vesi- 
cles and organelles to the leading edge, thereby position- 
ing them to respond further to a spreading signal. The ef- 
fect  of  colchicine  on  the  Raji  cells  may  suggest  that 
transport of molecules to the leading edge may be impor- 
tant for spreading to occur. It is unlikely that such mole- 
cules include syndecan-1 itself, as cell adhesion via synde- 
can is not impaired and surface staining for this protein 
appears undiminished upon colchicine treatment. 
In  preliminary  experiments  we  have  discovered  that 
treatment of the cells with compactin, a competitive inhib- 
itor of the isoprenylation of monomeric GTPases similar 
to lovastatin, adhere to mAb 281.2 but fail to spread. Al- 
though the action of this inhibitor remains to be clarified, 
it provides further demonstration that adhesion alone is 
insufficient to promote spreading. It is tempting to specu- 
late that the block to isoprenylation serves to deactivate 
the rho family of G-proteins, including rac, rho, and cdc42 
that are required for formation of lamellipodia, stress fi- 
bers,  and  filopodia,  respectively  (Kozma  et  al.,  1995; 
Nobes and Hall, 1995; Ridley and Hall, 1992; Ridley et al., 
1992). 
Although  the  syndecan-l-dependent spreading occurs 
without its cytoplasmic domain, this domain is likely none- 
theless to have an important role in the biology of synde- 
can-1. The cytoplasmic domain provides localization de- 
terminants  for basolateral  targeting of the  proteoglycan 
(Miettinen et al., 1994) and is required for actin filaments 
to cluster with antibody-induced aggregates of syndecan-1 
(Carey et al., 1994b). We have recently determined that 
the cytoplasmic domain of syndecan-1 is phosphorylated 
on tyrosine in pervanadate-stimulated NMuMG or Raji- 
S1 cells (Reiland, J., C. Lebakken, C. Yeaman, V. Ott, J. 
McCarthy,  and A.  Rapraeger,  manuscript submitted for 
publication). The identity of the kinase that carries out this 
phosphorylation remains unknown. 
The conclusion that the cytoplasmic domain is not re- 
quired for the syndecan-l-dependent spreading suggests 
that  signaling  is  mediated  through  another,  or  several, 
binding partners.  Truncation of the  cytoplasmic domain 
suggests that the interaction with binding partners is oc- 
curring through either the transmembrane domain or the 
extracellular domain of the core protein. Recently, a struc- 
tural  motif that  mediates  self-association of syndecan-3 
was defined that contains portions of both the transmem- 
brane  and  ectodomain of the core protein  (Asundi  and 
Carey, 1995). This motif is similar to those found in other 
transmembrane proteins that also homodimerize, includ- 
ing the  platelet-derived growth  factor receptor, 133 inte- 
grin, and glycophorin. The motif is suggested to maintain 
an extended conformation within the NH2-terminal half of 
the transmembrane region, rather than the more typical 
helical conformation. Syndecan-1 contains a similar motif, 
suggesting a mechanism for homodimerization at the cell 
membrane. This domain might also be used to generate 
heterotypic interactions with  syndecan-1  and  other pro- 
teins with similar motifs. 
Intracellular signals can be generated by a  number of 
cell surface receptors, ranging from growth factor recep- 
tors to membrane channels. Recently, cell adhesion mole- 
cules have been implicated more clearly in this process. In- 
tegrins, for example, are now known to activate kinases 
Lebakken and Rapraeger Syndecan-1 Mediates Cell Spreading  1219 such as focal adhesion kinase and src (for review see Rich- 
ardson and Parsons, 1995), leading to activation of other 
downstream signaling pathways.  Lymphoid cells such as 
the Raji line are known to express the integrin LFA-1 (O~L132) 
and the 131 integrins a3131  and 0t4131 (Ballard et al.,  1991; 
Rincon et al., 1992). Syndecan-1 may generate a signal by 
forming an assembly with these receptors or with other 
membrane-associated signaling molecules. 
Syndecan-1 appears to be involved in the maintenance 
of epithelial morphology. In NMuMG mammary epithelial 
cells, syndecan-1 colocalizes with the actin cytoskeleton at 
the basal  and  lateral  borders of cells  (Rapraeger et al., 
1986).  Also  expressed at  the  lateral borders are  E-cad- 
herin and 131 integrins, which have major roles in cell adhe- 
sion.  Surprisingly,  expression  of  syndecan-1  antisense 
mRNA in the NMuMG cells, which substantially reduces 
syndecan-1 protein expression, results in the loss of epithe- 
lial morphology (Kato et al., 1995). This suggests a role for 
syndecan-1  in  the  maintenance  of cell-cell  adhesion  in 
these cells, although this proteoglycan is apparently not a 
cell-cell adhesion molecule itself. This role is also indepen- 
dent of the heparan sulfate chains. Treatment of NMuMG 
cells with heparinases or with chlorate, which blocks sulfa- 
tion of the heparan sulfate and thus its ability to bind to its 
ligands, does not lead to a change in their epithelial char- 
acter (data not shown). Thus, the activity of the proteogly- 
can seems to be generated through the core protein, as de- 
scribed  herein.  The  reduction  in  syndecan-1  protein 
expression correlates with downregulation of E-cadherin 
and redistribution of 131 integrins (Kato et al., 1995). These 
results suggest that syndecan-1 protein may regulate cell- 
cell adhesion by binding to these receptors directly or by 
forming a signaling complex that regulates their distribu- 
tion and/or expression. 
It is becoming well documented that proteoglycans par- 
ticipate as coreceptors in the adherence and spreading of 
cells.  The glypican-like heparan  sulfate  proteoglycan in 
K1735 mouse melanoma cells mediates initial cell adhe- 
sion  to  fibronectin, thereby  allowing  lateral  association 
with other cell adhesion molecules that stabilize the adhe- 
sion and promote spreading (Drake et al., 1992). Schwann 
cells  transfected with  syndecan-1  also  exhibit  enhanced 
spreading on heparan sulfate ligands and form more focal 
contacts,  although  syndecan-1  is  not  localized  to  these 
structures (Carey et al., 1994a; Hansen et al.,  1994).  Simi- 
larly, formation of focal adhesions and stress fibers in fi- 
broblasts  requires  the  participation  of proteoglycan to- 
gether with integrins (Woods et al., 1986). Where explored 
in more detail in several types of cells, the generation of 
focal adhesions  containing ~5131 integrins  appears  to re- 
quire the colocalization of syndecan-4 (Woods and Couch- 
man,  1994).  A  model  is  proposed  whereby syndecan-4 
generates intracellular signals necessary for forming these 
adhesion  complexes.  In  another  example  of  signaling, 
NG2,  a  chondroitin  sulfate  proteoglycan on  melanoma 
cells, acts in concert with the Ot4131 integrin to achieve a 
fully spread morphology, including the presence of focal 
contacts. Either of these receptors can be engaged inde- 
pendently to generate the required signals, which appear 
to involve downstream tyrosine kinases (Iida et al., 1995). 
These  findings  demonstrate  that  proteoglycans  have 
more than a structural role in adhesion, participating as ac- 
tive signaling complexes at the cell surface. The ability of 
syndecan-1 to mediate cell spreading in Raji ceils suggests 
a similar mechanism. The ability of the protein to convey 
this  information without a  cytoplasmic domain suggests 
that the signaling mechanism must use other molecules in 
the  plasma  membrane.  Identification  of  this  signaling 
mechanism is likely to provide insight into how syndecan-1 
and other syndecans participate in the regulation of cell 
behavior. 
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